Literature DB >> 21795823

Cytokine levels in bronchoalveolar lavage and serum in 3 patients with 2009 Influenza A(H1N1)v severe pneumonia.

Angel Estella1.   

Abstract

INTRODUCTION: Pandemic Influenza A (H1N1)v pneumonia has led to a notable increase of admissions to intensive care units. A cytokine-mediated inflammatory response has been well documented in pneumonia and acute respiratory distress syndrome. However, few studies have focused on the role of these inflammatory mediators in infections caused by the Influenza A (H1N1)v. In this study, we assess the inflammatory response mediated by cytokines at the local and systemic levels in three cases of severe pneumonia caused by Influenza A (H1N1) virus.
METHODOLOGY: Serum and bronchoalveolar lavage samples were obtained from three mechanically ventilated patients diagnosed with Influenza A (H1N1) virus pneumonia by bronchoscopic bronchoalveolar lavage.  Levels of interleukin 6 (IL-6), interleukin 8 (IL-8), tumour necrosis factor alpha (TNFα) and interleukin 1 beta (IL-1ß) were meassured in these samples by enzyme-linked immunosorbent assay (ELISA).
RESULTS: High levels of C Reactive Protein, Procalcitonin below 1 ng/ml and absence of leukocytosis were common findings in all patients. TNFα and IL-1ß were not detected in the serum. IL-6 levels in serum were (94, pg/ml, 77 pg/ml and 84 pg/ml) respectively in the three patients, while IL-8 levels were (30,2 pg/ml, 128 pg/ml and 40,5 pg/ml). In the BAL samples, only one of the analysed cytokines, IL-1ß was present at detectable levels in two patients (21 pg/ml and 11 pg/ml respectively).
CONCLUSIONS: Our results support previous findings which suggest that high levels of IL-6 and IL-8 in serum somehow participate in the inflammatory response in severe cases of pandemic influenza pneumonia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795823     DOI: 10.3855/jidc.1618

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  9 in total

1.  In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1).

Authors:  Matthew T Rondina; BreAnna Brewster; Colin K Grissom; Guy A Zimmerman; Diana H Kastendieck; Estelle S Harris; Andrew S Weyrich
Journal:  Chest       Date:  2012-03-01       Impact factor: 9.410

Review 2.  Genetic influences on viral-induced cytokine responses in the lung.

Authors:  Jessica L Forbester; Ian R Humphreys
Journal:  Mucosal Immunol       Date:  2020-11-12       Impact factor: 7.313

3.  Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.

Authors:  Lynette Miroslava Pacheco-Hernández; Jazmín Ariadna Ramírez-Noyola; Itzel Alejandra Gómez-García; Sergio Ignacio-Cortés; Joaquín Zúñiga; José Alberto Choreño-Parra
Journal:  J Interferon Cytokine Res       Date:  2022-06-07       Impact factor: 3.657

4.  Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19.

Authors:  Younes Zaid; Étienne Doré; Isabelle Dubuc; Anne-Sophie Archambault; Olivier Flamand; Michel Laviolette; Nicolas Flamand; Éric Boilard; Louis Flamand
Journal:  J Allergy Clin Immunol       Date:  2021-06-07       Impact factor: 10.793

5.  Characterization in vitro and in vivo of a pandemic H1N1 influenza virus from a fatal case.

Authors:  Ariel Rodriguez; Ana Falcon; Maria Teresa Cuevas; Francisco Pozo; Susana Guerra; Blanca García-Barreno; Pamela Martinez-Orellana; Pilar Pérez-Breña; Maria Montoya; Jose Antonio Melero; Manuel Pizarro; Juan Ortin; Inmaculada Casas; Amelia Nieto
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

6.  The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies.

Authors:  Richard T Davey; Ruth Lynfield; Dominic E Dwyer; Marcello H Losso; Alessandro Cozzi-Lepri; Deborah Wentworth; H Clifford Lane; Robin Dewar; Adam Rupert; Julia A Metcalf; Sarah L Pett; Timothy M Uyeki; Jose Maria Bruguera; Brian Angus; Nathan Cummins; Jens Lundgren; James D Neaton
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

7.  IL-1 β and IL-6 upregulation in children with H1N1 influenza virus infection.

Authors:  Antonio Chiaretti; Silvia Pulitanò; Giovanni Barone; Pietro Ferrara; Valerio Romano; Domenico Capozzi; Riccardo Riccardi
Journal:  Mediators Inflamm       Date:  2013-04-29       Impact factor: 4.711

8.  TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population.

Authors:  Román Alejandro García-Ramírez; Alejandra Ramírez-Venegas; Roger Quintana-Carrillo; Ángel Eduardo Camarena; Ramcés Falfán-Valencia; Juan Manuel Mejía-Aranguré
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

9.  Genetic variants in IL1A and IL1B contribute to the susceptibility to 2009 pandemic H1N1 influenza A virus.

Authors:  Yingxia Liu; Shaoyuan Li; Guoliang Zhang; Guang Nie; Zhizhong Meng; Dongting Mao; Chang Chen; Xinchun Chen; Boping Zhou; Gucheng Zeng
Journal:  BMC Immunol       Date:  2013-08-08       Impact factor: 3.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.